Integrated Core Proteomics, Subtractive Proteomics, and Immunoinformatics Investigation to Unveil a Potential Multi-Epitope Vaccine against Schistosomiasis
Open Access
- 16 June 2021
- Vol. 9 (6), 658
- https://doi.org/10.3390/vaccines9060658
Abstract
Schistosomiasis is a parasitic infection that causes considerable morbidity and mortality in the world. Infections of parasitic blood flukes, known as schistosomes, cause the disease. No vaccine is available yet and thus there is a need to design an effective vaccine against schistosomiasis. Schistosoma japonicum, Schistosoma mansoni, and Schistosoma haematobium are the main pathogenic species that infect humans. In this research, core proteomics was combined with a subtractive proteomics pipeline to identify suitable antigenic proteins for the construction of a multi-epitope vaccine (MEV) against human-infecting Schistosoma species. The pipeline revealed two antigenic proteins—calcium binding and mycosubtilin synthase subunit C—as promising vaccine targets. T and B cell epitopes from the targeted proteins were predicted using multiple bioinformatics and immunoinformatics databases. Seven cytotoxic T cell lymphocytes (CTL), three helper T cell lymphocytes (HTL), and four linear B cell lymphocytes (LBL) epitopes were fused with a suitable adjuvant and linkers to design a 217 amino-acid-long MEV. The vaccine was coupled with a TLR-4 agonist (RS-09; Sequence: APPHALS) adjuvant to enhance the immune responses. The designed MEV was stable, highly antigenic, and non-allergenic to human use. Molecular docking, molecular dynamics (MD) simulations, and molecular mechanics/generalized Born surface area (MMGBSA) analysis were performed to study the binding affinity and molecular interactions of the MEV with human immune receptors (TLR2 and TLR4) and MHC molecules (MHC I and MHC II). The MEV expression capability was tested in an Escherichia coli (strain-K12) plasmid vector pET-28a(+). Findings of these computer assays proved the MEV as highly promising in establishing protective immunity against the pathogens; nevertheless, additional validation by in vivo and in vitro experiments is required to discuss its real immune-protective efficacy.Keywords
This publication has 125 references indexed in Scilit:
- AllerTOP - a server for in silico prediction of allergensBMC Bioinformatics, 2013
- Homology modeling and virtual screening approaches to identify potent inhibitors of VEB-1 β-lactamaseTheoretical Biology and Medical Modelling, 2013
- GalaxyWEB server for protein structure prediction and refinementNucleic Acids Research, 2012
- Immune system simulation onlineBioinformatics, 2011
- High-throughput prediction of protein antigenicity using protein microarray dataBioinformatics, 2010
- Determination of Ensemble-Average Pairwise Root Mean-Square Deviation from Experimental B-FactorsBiophysical Journal, 2010
- CD-HIT Suite: a web server for clustering and comparing biological sequencesBioinformatics, 2010
- ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteinsNucleic Acids Research, 2007
- Predicting transmembrane protein topology with a hidden markov model: application to complete genomesJournal of Molecular Biology, 2001
- Molecular dynamics with coupling to an external bathThe Journal of Chemical Physics, 1984